News & Updates

Glucocorticoid users risk developing hypertension

14 Jul 2020

Use of glucocorticoid at doses ≥7.5 mg poses an increased risk of incident hypertension among patients with rheumatoid arthritis, a study has found.

Glucocorticoid users risk developing hypertension

14 Jul 2020

Netakimab improves treatment outcomes in PsA

09 Jul 2020 by

The anti-interleukin 17A antibody netakimab reduces disease activity and skin manifestations in patients with active psoriatic arthritis (PsA), consequently improving patient-reported outcomes (PROs), analyses of the phase III PATERA trial have shown.

Netakimab improves treatment outcomes in PsA

09 Jul 2020

Novel JAK1 inhibitor on par with adalimumab in RA over 52 weeks

08 Jul 2020 by

The investigational JAK1* inhibitor filgotinib was noninferior to adalimumab in reducing disease activity in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate response to methotrexate (MTX-IR), according to the FINCH 1 study presented at EULAR 2020 Virtual Meeting.

Novel JAK1 inhibitor on par with adalimumab in RA over 52 weeks

08 Jul 2020

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020 by

Upadacitinib may be a suitable treatment for patients with active psoriatic arthritis (PsA) who have insufficient response to non-biologic disease-modifying anti-rheumatic drugs (non-bDMARDs), according to results of the phase III SELECT-PsA-1* trial presented at EULAR 2020.

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

08 Jul 2020

Vitamin D, fish oil supplementation of no benefit to adults with chronic knee pain

08 Jul 2020

Long-term supplementation of vitamin D and marine omega‐3 fatty acids in adults with chronic knee pain turns out to be fruitless, yielding no favourable effect on knee pain, function, or stiffness, as shown in a study.

Vitamin D, fish oil supplementation of no benefit to adults with chronic knee pain

08 Jul 2020

Is ticagrelor protective against osteoarthritis too?

08 Jul 2020 by

Ticagrelor reduces the risk of developing osteoarthritis by about 30 percent compared with another antiplatelet, clopidogrel, as shown in a recent study.

Is ticagrelor protective against osteoarthritis too?

08 Jul 2020

Apremilast improves oral ulcers in patients with Behçet’s syndrome

08 Jul 2020 by

Treatment with apremilast, an oral phosphodiesterase 4 inhibitor, significantly reduced the number of oral ulcers in patients with Behcet’s syndrome, according to the RELIEF* study presented at EULAR 2020.

Apremilast improves oral ulcers in patients with Behçet’s syndrome

08 Jul 2020

Lower joint replacement risk yet another benefit of statins

06 Jul 2020

Routinely used for treating cardiovascular diseases, statins have been shown to benefit other conditions, and new evidence suggests that using the drug at high intensity reduces the risk of hip or knee replacement, an effect that may be specific to rheumatoid arthritis.

Lower joint replacement risk yet another benefit of statins

06 Jul 2020

General risk algorithms inaccurately predict CV risk in rheumatic patients

01 Jul 2020

Cardiovascular (CV) risk prediction algorithms tend to be inaccurate, frequently underestimating and sometimes overestimating the risk of CV in patients with inflammatory rheumatic diseases, a recent study has shown.

General risk algorithms inaccurately predict CV risk in rheumatic patients

01 Jul 2020

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients

30 Jun 2020

Patients with psoriatic arthritis (PsA) often suffer from liver abnormalities, which are associated with higher body mass index (BMI), daily consumption of alcohol, more severe disease, and some therapies, according to a recent study.

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients

30 Jun 2020

News & Updates

Filter by Specialty:

Specialty:

Glucocorticoid users risk developing hypertension

Glucocorticoid users risk developing hypertension

Netakimab improves treatment outcomes in PsA

Netakimab improves treatment outcomes in PsA

Novel JAK1 inhibitor on par with adalimumab in RA over 52 weeks

Novel JAK1 inhibitor on par with adalimumab in RA over 52 weeks

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

SELECT-PsA-1 demos upadacitinib benefits in psoriatic arthritis

Vitamin D, fish oil supplementation of no benefit to adults with chronic knee pain

Vitamin D, fish oil supplementation of no benefit to adults with chronic knee pain

Is ticagrelor protective against osteoarthritis too?

Is ticagrelor protective against osteoarthritis too?

Apremilast improves oral ulcers in patients with Behçet’s syndrome

Apremilast improves oral ulcers in patients with Behçet’s syndrome

Lower joint replacement risk yet another benefit of statins

Lower joint replacement risk yet another benefit of statins

General risk algorithms inaccurately predict CV risk in rheumatic patients

General risk algorithms inaccurately predict CV risk in rheumatic patients

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients

Daily alcohol intake, certain drugs tied to liver abnormalities in PsA patients